Update: Dr. Berne’s MSM Eye Drops Are Voluntarily Recalled
All eye drops from Dr. Berne’s Whole Health Products are being recalled after FDA warning on August 24. There are 2 adverse reactions reported so far.
Check the brand of eye drops you use. Several have been recalled in the last 8 months, including Dr. Berne's.
(Adobe Stock 1280228575 by puhhha)
After the US Food and Drug Administration issued warnings to stop using and discard Dr. Berne’s MSM Drops 5% Solution on August 24, 2023, Dr. Berne’s Whole Health Products has voluntarily recalled MSM Drops 5%, 15% Solution, Dr. Berne’s Organic Castor Oil Eye Drops and Dr. Berne’s MSM MIST 15% Solution. All lots for all products are being recalled.
According to the risk statement: “Using contaminated eye drops could result in minor to serious vision-threatening infection which could possibly progress to a life-threatening infection. To date, Dr. Berne’s has received 2 reports of adverse events related to this recall.”
Dr. Berne's webstore distributed Dr. Berne's Organic Castor Oil Eye Drops and Dr. Berne's MSM MIST 15% Solution, both packaged in 30mL/1fl oz white plastic bottles, used as lubricating eye drops.
As Infection Control Today® reported, some of the contamination of the Dr. Berne’s MSM Drops 5% Solution were Bacillus, spp. and Exophiala, spp.
The FDA discovered contamination in recent batches of eye drops during testing, which violates the Federal Food, Drug and Cosmetic Act that requires eye drops to be sterile for safe use.
The eye drop products from Dr. Berne contain the unapproved active ingredient, methylsulfonylmethane (MSM), and lack sterility. No ophthalmic drugs with MSM are legally marketed in the US.
Prior to this recall, the FDA warned against using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops—Eye Repair due to bacterial and fungal contamination. FDA notified LightEyez Limited of contaminated products on August 21, 2023, but received no response. Additionally, the company has not taken action to protect consumers from using the contaminated eye drops, according to the FDA.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
